JZ-14 / Yunnan Baiyao - LARVOL DELTA

Yunnan Baiyao (000538.SZ): Clinical trial application for JZ-14 capsule approved (Zhitong Finance) - "According to the Zhitong Finance APP, Yunnan Baiyao...announced that its holding subsidiary Yunnan Baiyao Zhengwu Technology (Shanghai) Co., Ltd. (hereinafter referred to as 'Zhengwu Technology') recently received the 'Drug Clinical Trial Approval Notice' issued by the State Drug Administration. After review, Zhengwu Technology's JZ-14 capsule clinical trial application meets the relevant requirements for drug registration, and it is approved to conduct clinical trials of this product for ulcerative colitis."

New trial • Ulcerative Colitis